特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
297189

間葉系幹細胞の世界市場

Mesenchymal Stem Cells (MSC)

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 185 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.59円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

間葉系幹細胞の世界市場
出版日: 2020年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、間葉系幹細胞 (MSC) の世界市場について分析しております。また米国、カナダ、日本、欧州、アジア太平洋地域およびその他の地域の各地域についてそれぞれ包括的分析を提供すると共に、2015年から2022年までの各年ごとの見積りと予測をお伝え致します。さらに主要企業とニッチ企業を含む47社のプロファイルを交えつつ、概略下記内容でお届け致します。

第1章 イントロダクション・分析手法・製品定義

第2章 市場概要

  • 間葉系幹細胞 (MSC) 市場:急速な成長過程
  • 現状/将来分析
  • MSC治療の現状と将来性
    • MSCベースの治療法の選択
  • 間葉系幹細胞の関連分析・治験
    • 完了済みの第III相治験
  • MSCの新たな治療領域を開拓する試み
  • 「オフザシェルフ」MSCの大規模な商業化が、現実のものとなる
  • ブームに便乗しようとするソフトウェア企業

第3章 市場の促進要因・動向・課題

  • 再生医療の発達がMSCの需要を促進
  • 人口の高齢化がMSC療法の需要を促進
    • 世界の高齢者人口の統計データ:市場機会の指標
  • 慢性疾患の患者増加が、MSCの需要を促進
    • 主要疾患の統計データ:市場機会の指標
  • 整形外科手術の件数増加:MSCの市場機会
  • 胚性幹細胞研究についての議論が止まないのに対し、成体幹細胞療法は成長軌道に乗っている
    • 成体幹細胞および胚性幹細胞 - 比較
  • 間葉系幹細胞 vs 胚性/人工多能性幹細胞
  • 間葉系幹細胞療法は、胚性幹細胞に適用される倫理問題の影響を受けない
  • 間葉系幹細胞:「標的化ドラッグデリバリー」に使える可能性のある運搬手段
  • 幹細胞関連の骨移植片:今後の市場成長の見込み
  • 生体内特性に関連した抜け穴が、治療法の進歩を促す
  • 間葉系幹細胞市場に立ちはだかる大きな課題
  • 同種異系の間葉系幹細胞:免疫抑制/組織修復治療の分野での市場機会
  • 間葉系幹細胞の有効性を左右する投与経路

第4章 主要な幹細胞変異体の分析

  • 成体幹細胞
    • 低リスクの投資
    • 成体幹細胞は研究用投資をさらに集める
    • 多様性の低さ - 成体幹細胞の主な制約要因
  • 造血幹細胞 - 不朽の成功を収める
    • 制約要因
  • 人工多能性幹細胞 (iPS細胞) - ESCの代替品
    • iPSの発見
    • 医薬品開発 - IPSの主な活用分野
    • 再生医療のためのiPSの使用
    • iPS細胞バンクの確立
  • 難治性/先天性疾患の治療
  • 医学を変貌させる胚性幹細胞
    • 倫理問題や技術的なハードルがhESC研究を足踏みさせる
  • 安全性と有効性のデータの不足 - 主な懸念

第5章 間葉系幹細胞 (MSC) 市場の分析:用途別

  • 整形外科における間葉系幹細胞
    • 整形手術のための間葉系幹細胞ベースのモデル
    • 療法を必要とする領域への間葉系幹細胞の供給
    • 変形性関節症治療における間葉系幹細胞
    • 関節リウマチ治療における間葉系幹細胞
  • がん治療における間葉系幹細胞
  • 肝臓学における間葉系幹細胞
  • 神経学における間葉系幹細胞
  • 心臓病における間葉系幹細胞
  • 放射線治療における間葉系幹細胞
  • 糖尿病治療における間葉系幹細胞
  • 自己免疫疾患治療における間葉系幹細胞
    • 放射線治療における間葉系幹細胞
  • 早発卵巣不全 (POF) 治療における間葉系幹細胞
  • 遺伝子治療における間葉系幹細胞
  • 肺疾患治療における間葉系幹細胞
  • 肝臓病治療における間葉系幹細胞
  • 多発性硬化症 (MS) 治療における間葉系幹細胞
  • 結腸修復における間葉系幹細胞
  • 腎修復における間葉系幹細胞

第6章 製品概要

  • 間葉系幹細胞(MSC)- はじめに
  • 歴史
  • 同種間葉系幹細胞とは何か?
  • 間葉系幹細胞のいくつかの主な供給源
    • 骨髄
    • ウォートンゼリー、臍帯血
    • 脂肪組織
    • 栄養膜組織
    • 羊水
    • 下顎智歯の歯芽を開発
  • 間葉系幹細胞治療のメカニズム
  • 間葉系幹細胞の重要な機能
    • 形態学
    • 識別/検出
    • 分化能
    • 免疫調節作用
    • 培養
  • 臨床用途
  • 臨床グレードMSCの生産
  • 間葉系幹細胞 (MSC) の欠点

第7章 競争環境

  • 主要企業の分析
  • 製品発売動向
  • 最近の業界活動

第8章 世界市場の将来展望

第9章 世界各地の市場の将来展望

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
  • 他の国々 (RoW)

第10章 企業プロファイル

  • 主要企業の概略
目次
Product Code: MCP-7815

Global Mesenchymal Stem Cells (MSC) Market to Reach $229 Million by 2027

Amid the COVID-19 crisis, the global market for Mesenchymal Stem Cells (MSC) estimated at US$172.9 Million in the year 2020, is projected to reach a revised size of US$229 Million by 2027, growing at a CAGR of 4.1% over the analysis period 2020-2027. Human MSC, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$94.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Mouse MSC segment is readjusted to a revised 4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $50.9 Million, While China is Forecast to Grow at 3.9% CAGR

The Mesenchymal Stem Cells (MSC) market in the U.S. is estimated at US$50.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$40.6 Million by the year 2027 trailing a CAGR of 3.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 3.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Rat MSC Segment to Record 3.8% CAGR

In the global Rat MSC segment, USA, Canada, Japan, China and Europe will drive the 3.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$27.7 Million in the year 2020 will reach a projected size of US$36.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$25.5 Million by the year 2027.We bring years of research experience to this 19th edition of our report. The 185-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Cell Applications Inc.
  • Celprogen Inc.
  • Cyagen US Inc.
  • Genlantis Inc.
  • Lonza Group
  • Mesoblast Limited
  • MilliporeSigma
  • Neuromics
  • Orthofix International N.V.
  • PromoCell GmbH
  • R&D Systems Inc.
  • ScienCell Research Laboratories
  • Stemcell Technologies Inc.
  • Stemedica Cell Technologies Inc.
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Mesenchymal Stem Cells Market on a Rapid Growth Path
    • Recent Market Activity
    • Current and Future Analysis
    • The Present and Future of MSC Therapies
    • Select MSC-based Therapeutics
    • Mesenchymal Stem Cell Research
    • Completed Phase III Studies with MSCs
    • MSCs are Being Explored for Several New Treatment Possibilities
    • Widespread Commercialization of 'Off-the-Shelf' MSCs to Become a Reality
    • Software Companies Endeavour to Cash in on the Boom
    • Global Competitor Market Shares
    • Mesenchymal Stem Cells (MSC) Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • Cell Applications, Inc. (USA)
    • Celprogen, Inc. (USA)
    • Cyagen US Inc. (USA)
    • Genlantis, Inc. (USA)
    • Lonza Group (Switzerland)
    • Mesoblast Limited (Australia)
    • MilliporeSigma (USA)
    • Neuromics (USA)
    • Orthofix International N.V. (Italy)
    • PromoCell GmbH (Germany)
    • R&D Systems, Inc. (USA)
    • ScienCell Research Laboratories (USA)
    • Stemcell Technologies Inc. (Canada)
    • Stemedica Cell Technologies, Inc. (USA)
    • Thermo Fischer Scientific, Inc. (USA)
    • Vitro Biopharma (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Development of Regenerative Medicine Accelerates Demand for MSCs
    • Ageing Demographics to Drive Demand for Mesenchymal Stem Cell Therapies
    • Global Aging Population Statistics - Opportunity Indicators
    • Growing Prevalence of Chronic Diseases Propels Demand for Mesenchymal Stem Cells
    • Key Disease Statistics - Opportunity Indicators
    • Growing Volume of Orthopedic Procedures: An Opportunity for the MSC Market
    • Adult Stem Cell Therapies on Growth Trajectory, as Controversies Continue to Haunt Embryonic Stem Cell Research
    • Adult Stem Cells and Embryonic Stem Cells - A Comparison
    • MSCs Versus Embryonic or Induced Pluripotent Stem Cells
    • MSC Therapies - Immune to Ethical Issues Applicable to Embryonic Stem Cells
    • MSCs - A Potential Vehicle for 'Targeted Drug Delivery'
    • Stem Cell Based Bone Grafts: Promising Growth Ahead
    • Loopholes Associated with In Vivo Properties Constrain Therapeutic Advancements
    • Major Challenges Confronting Mesenchymal Stem Cell Market
    • Allogeneic MSCs - Offering Promise in Immunosuppressive and Tissue Repair Therapy
    • Administration Route Determines the Effectiveness of MSCs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: Mesenchymal Stem Cells (MSC) Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
    • TABLE 2: Mesenchymal Stem Cells (MSC) Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019
    • TABLE 3: Mesenchymal Stem Cells (MSC) Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
    • TABLE 4: Human MSC (Type) World Market by Region/Country in US$ Thousand: 2020 to 2027
    • TABLE 5: Human MSC (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019
    • TABLE 6: Human MSC (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 7: Mouse MSC (Type) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
    • TABLE 8: Mouse MSC (Type) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019
    • TABLE 9: Mouse MSC (Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
    • TABLE 10: Rat MSC (Type) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027
    • TABLE 11: Rat MSC (Type) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019
    • TABLE 12: Rat MSC (Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 13: Other Types (Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027
    • TABLE 14: Other Types (Type) Market Historic Review by Region/Country in US$ Thousand: 2012 to 2019
    • TABLE 15: Other Types (Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 16: Research Institutes (Application) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027
    • TABLE 17: Research Institutes (Application) Global Historic Analysis in US$ Thousand by Region/Country: 2012-2019
    • TABLE 18: Research Institutes (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 19: Hospitals (Application) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through 2027
    • TABLE 20: Hospitals (Application) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2012 to 2019
    • TABLE 21: Hospitals (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
    • TABLE 22: Other Applications (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027
    • TABLE 23: Other Applications (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019
    • TABLE 24: Other Applications (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Mesenchymal Stem Cells (MSC) Market Share (in %) by Company: 2018 & 2025
    • Market Analytics
    • TABLE 25: United States Mesenchymal Stem Cells (MSC) Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027
    • TABLE 26: Mesenchymal Stem Cells (MSC) Market in the United States by Type: A Historic Review in US$ Thousand for 2012-2019
    • TABLE 27: United States Mesenchymal Stem Cells (MSC) Market Share Breakdown by Type: 2012 VS 2020 VS 2027
    • TABLE 28: United States Mesenchymal Stem Cells (MSC) Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027
    • TABLE 29: Mesenchymal Stem Cells (MSC) Historic Demand Patterns in the United States by Application in US$ Thousand for 2012-2019
    • TABLE 30: Mesenchymal Stem Cells (MSC) Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 31: Canadian Mesenchymal Stem Cells (MSC) Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027
    • TABLE 32: Canadian Mesenchymal Stem Cells (MSC) Historic Market Review by Type in US$ Thousand: 2012-2019
    • TABLE 33: Mesenchymal Stem Cells (MSC) Market in Canada: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027
    • TABLE 34: Canadian Mesenchymal Stem Cells (MSC) Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027
    • TABLE 35: Mesenchymal Stem Cells (MSC) Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2012-2019
    • TABLE 36: Canadian Mesenchymal Stem Cells (MSC) Market Share Analysis by Application: 2012 VS 2020 VS 2027
  • JAPAN
    • TABLE 37: Japanese Market for Mesenchymal Stem Cells (MSC): Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027
    • TABLE 38: Mesenchymal Stem Cells (MSC) Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019
    • TABLE 39: Japanese Mesenchymal Stem Cells (MSC) Market Share Analysis by Type: 2012 VS 2020 VS 2027
    • TABLE 40: Japanese Demand Estimates and Forecasts for Mesenchymal Stem Cells (MSC) in US$ Thousand by Application: 2020 to 2027
    • TABLE 41: Japanese Mesenchymal Stem Cells (MSC) Market in US$ Thousand by Application: 2012-2019
    • TABLE 42: Mesenchymal Stem Cells (MSC) Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 43: Chinese Mesenchymal Stem Cells (MSC) Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027
    • TABLE 44: Mesenchymal Stem Cells (MSC) Historic Market Analysis in China in US$ Thousand by Type: 2012-2019
    • TABLE 45: Chinese Mesenchymal Stem Cells (MSC) Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 46: Chinese Demand for Mesenchymal Stem Cells (MSC) in US$ Thousand by Application: 2020 to 2027
    • TABLE 47: Mesenchymal Stem Cells (MSC) Market Review in China in US$ Thousand by Application: 2012-2019
    • TABLE 48: Chinese Mesenchymal Stem Cells (MSC) Market Share Breakdown by Application: 2012 VS 2020 VS 2027
  • EUROPE
    • Market Facts & Figures
    • European Mesenchymal Stem Cells (MSC) Market: Competitor Market Share Scenario (in %) for 2018 & 2025
    • Market Analytics
    • TABLE 49: European Mesenchymal Stem Cells (MSC) Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027
    • TABLE 50: Mesenchymal Stem Cells (MSC) Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019
    • TABLE 51: European Mesenchymal Stem Cells (MSC) Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 52: European Mesenchymal Stem Cells (MSC) Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027
    • TABLE 53: Mesenchymal Stem Cells (MSC) Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2012-2019
    • TABLE 54: European Mesenchymal Stem Cells (MSC) Market Share Breakdown by Type: 2012 VS 2020 VS 2027
    • TABLE 55: European Mesenchymal Stem Cells (MSC) Addressable Market Opportunity in US$ Thousand by Application: 2020-2027
    • TABLE 56: Mesenchymal Stem Cells (MSC) Market in Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2012-2019
    • TABLE 57: European Mesenchymal Stem Cells (MSC) Market Share Analysis by Application: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 58: Mesenchymal Stem Cells (MSC) Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 59: French Mesenchymal Stem Cells (MSC) Historic Market Scenario in US$ Thousand by Type: 2012-2019
    • TABLE 60: French Mesenchymal Stem Cells (MSC) Market Share Analysis by Type: 2012 VS 2020 VS 2027
    • TABLE 61: Mesenchymal Stem Cells (MSC) Quantitative Demand Analysis in France in US$ Thousand by Application: 2020-2027
    • TABLE 62: French Mesenchymal Stem Cells (MSC) Historic Market Review in US$ Thousand by Application: 2012-2019
    • TABLE 63: French Mesenchymal Stem Cells (MSC) Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
  • GERMANY
    • TABLE 64: Mesenchymal Stem Cells (MSC) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027
    • TABLE 65: German Mesenchymal Stem Cells (MSC) Historic Market Analysis in US$ Thousand by Type: 2012-2019
    • TABLE 66: German Mesenchymal Stem Cells (MSC) Market Share Breakdown by Type: 2012 VS 2020 VS 2027
    • TABLE 67: Mesenchymal Stem Cells (MSC) Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027
    • TABLE 68: German Mesenchymal Stem Cells (MSC) Market in Retrospect in US$ Thousand by Application: 2012-2019
    • TABLE 69: Mesenchymal Stem Cells (MSC) Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 70: Italian Mesenchymal Stem Cells (MSC) Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027
    • TABLE 71: Mesenchymal Stem Cells (MSC) Historic Market Analysis in Italy in US$ Thousand by Type: 2012-2019
    • TABLE 72: Italian Mesenchymal Stem Cells (MSC) Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 73: Italian Demand for Mesenchymal Stem Cells (MSC) in US$ Thousand by Application: 2020 to 2027
    • TABLE 74: Mesenchymal Stem Cells (MSC) Market Review in Italy in US$ Thousand by Application: 2012-2019
    • TABLE 75: Italian Mesenchymal Stem Cells (MSC) Market Share Breakdown by Application: 2012 VS 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 76: United Kingdom Market for Mesenchymal Stem Cells (MSC): Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027
    • TABLE 77: Mesenchymal Stem Cells (MSC) Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019
    • TABLE 78: United Kingdom Mesenchymal Stem Cells (MSC) Market Share Analysis by Type: 2012 VS 2020 VS 2027
    • TABLE 79: United Kingdom Demand Estimates and Forecasts for Mesenchymal Stem Cells (MSC) in US$ Thousand by Application: 2020 to 2027
    • TABLE 80: United Kingdom Mesenchymal Stem Cells (MSC) Market in US$ Thousand by Application: 2012-2019
    • TABLE 81: Mesenchymal Stem Cells (MSC) Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Mesenchymal Stem Cells (MSC) Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027
    • TABLE 83: Mesenchymal Stem Cells (MSC) Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2012-2019
    • TABLE 84: Rest of Europe Mesenchymal Stem Cells (MSC) Market Share Breakdown by Type: 2012 VS 2020 VS 2027
    • TABLE 85: Rest of Europe Mesenchymal Stem Cells (MSC) Addressable Market Opportunity in US$ Thousand by Application: 2020-2027
    • TABLE 86: Mesenchymal Stem Cells (MSC) Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2012-2019
    • TABLE 87: Rest of Europe Mesenchymal Stem Cells (MSC) Market Share Analysis by Application: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 88: Mesenchymal Stem Cells (MSC) Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 89: Asia-Pacific Mesenchymal Stem Cells (MSC) Historic Market Scenario in US$ Thousand by Type: 2012-2019
    • TABLE 90: Asia-Pacific Mesenchymal Stem Cells (MSC) Market Share Analysis by Type: 2012 VS 2020 VS 2027
    • TABLE 91: Mesenchymal Stem Cells (MSC) Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2020-2027
    • TABLE 92: Asia-Pacific Mesenchymal Stem Cells (MSC) Historic Market Review in US$ Thousand by Application: 2012-2019
    • TABLE 93: Asia-Pacific Mesenchymal Stem Cells (MSC) Market Share Analysis: A 17-Year Perspectiveby Application for 2012, 2020, and 2027
  • REST OF WORLD
    • TABLE 94: Rest of World Mesenchymal Stem Cells (MSC) Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027
    • TABLE 95: Rest of World Mesenchymal Stem Cells (MSC) Historic Market Review by Type in US$ Thousand: 2012-2019
    • TABLE 96: Mesenchymal Stem Cells (MSC) Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027
    • TABLE 97: Rest of World Mesenchymal Stem Cells (MSC) Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027
    • TABLE 98: Mesenchymal Stem Cells (MSC) Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2012-2019
    • TABLE 99: Rest of World Mesenchymal Stem Cells (MSC) Market Share Analysis by Application: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 47
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.